Articles

Poll

Podcasts

Slideshows

Videos

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Ten percent of effector genes identified express proteins targeted by approved drugs across disease fields.

Largest Osteoarthritis GWAS to Date Highlights Opportunities for Drug Repurposing and Novel Targets

Investigators call for faster diagnosis and better treatment for psoriatic arthritis to avoid unnecessary complication and suffering.

Study Finds Diagnostic Delay, Less Intensive Therapy Use in PsA than RA

Anti-IL-17 medications meant to treat psoriasis and psoriatic arthritis may inadvertently harm gastrointestinal tract.

IL-17 Inhibitors May Raise Inflammatory Bowel Disease Risk, New Study Suggests

hsCRP may be a more accessible and reliable method of indicating inflammation, a known precursor to PsA.

High Sensitivity C-Reactive Protein May Predict Psoriatic Arthritis

The rheumatology month in review emphasizes new research in gout, fibromyalgia, and psoriatic arthritis.

Rheumatology Month in Review: March 2025

Small but significant decreases were also seen in depression and anxiety scores in people with and without psoriatic arthritis.

Weight Loss Intervention Improved Health-Related QoL in People With and Without PsA

Hazard ratios of MACE were similar between patients treated with ustekinumab, adalimumab, etanercept, and secukinumab.

Ustekinumab, Other Biologics for PsA and PsO Have Similar Cardiovascular Safety

A newly passed bill permits 2.8% Medicare physician payment cuts.

AMA, ACR, Others Say Medicare Cuts Will Impact Access to Care

Mease discussed recent research on what matters in PsA care between patients and clinicians.

Considering Patient Priorities in PsA Care, with Philip Mease, MD

Data from the POETYK PsA-2 trial examining deucravacitinib were presented at the 2025 American Academy of Dermatology annual meeting.

Deucravacitinib Improves PsA Symptoms and Quality of Life in POETYK PsA-2

On the HCPLive psoriatic arthritis page, resources on the topics of medical news and expert insight into PsA can be found. Content includes articles, interviews, videos, podcasts, and breaking news on arthritis, and more.